Dr. Abdulhadi Aljawish | Cytotoxicity | Best Researcher Award

Posted on by Pencis

Dr. Abdulhadi Aljawish | Cytotoxicity | Best Researcher Award

National Conservatory of Arts and Crafts | France

Author Profile

Scopus

Google Scholar

Biography: Dr. Abdulhadi ALJAWISH

🧑‍🔬 Education

2009-2013: Ph.D. in Biotechnological and Food Processes (with Honors)
Laboratoire d’Ingénierie des Biomolécules-ENSAIA, Université de Lorraine, Nancy, France
Thesis: “Enzymatic functionalization of chitosan with phenolic compounds by Myceliophthora thermophila laccase”
Advisors: Prof. Joël SCHER, Prof. Isabelle CHEVALOT
Defense Date: 08/07/2013

2008-2009: Master’s in Biotechnology, Agro-resources, Food, Nutrition (B.A.A.N) (with Merit)
Laboratoire de Biocatalyse-Bioprocédés (LBB), ENSAIA-INPL, Nancy, France
Research: “Enzymatic synthesis of natural colorants from phenolic compounds”
Advisors: Prof. Michel GIRARDIN, Dr. Lionel MUNIGLIA

👨‍💼 Professional Experience

2021-2023: Head of Research & Development in Enzymatic Processes
SAS GECCO, Institut Charles VIOLLETTE – Laboratoire des Procédés Biologiques, Génie Enzymatique et Microbien (ProBioGem), Université de Lille, Lille, France

2019-2021: Research & Development Engineer in Enzymatic Processes
SAS GECCO, Institut Charles VIOLLETTE – Laboratoire des Procédés Biologiques, Génie Enzymatique et Microbien (ProBioGem), Université de Lille, Lille, France

2016-2018: Postdoctoral Fellow in Biocatalysis – Bioprocesses
Institut Charles VIOLLETTE – Laboratoire des Procédés Biologiques, Génie Enzymatique et Microbien (ProBioGem), Université de Lille, Lille, France

2015-2016: Postdoctoral Fellow in Biochemistry – Toxicology
Institut de Chimie Moléculaire (ICMUB-UMR-CNRS6302), Université de Bourgogne, Dijon, France
Laboratoire de Nutrition et Toxicologie (NuTox), INSERM -UMR U866-Agrosup, Dijon, France

2013-2015: Temporary Teaching and Research Attaché (ATER) in Biochemistry – Food Biotechnology
École nationale supérieure d’agronomie et des industries alimentaires (ENSAIA), Université de Lorraine, Nancy, France

2009-2013: Ph.D. Researcher in Biotechnology and Food Processes
Laboratoire d’Ingénierie des Biomolécules (LIBio), Laboratoire Réactions et Génie des procédés (LRGP)-ENSAIA, Université de Lorraine, Nancy, France

📚 Supervision and Collective Responsibilities

  • Supervised several Master’s and Ph.D. students in various projects related to enzymatic purification, functionalization, and biotests development.
  • Managed projects on the valorization of food waste and biodiesel by-products, emphasizing circular economy principles.

🧬 Skills and Expertise

  • Circular Economy: Valorization of food waste and biomass, biodiesel production, energy recovery.
  • Biosynthesis/Biocatalysis: Enzyme purification and characterization, oxidative processes, esterification, transesterification, kinetic studies, various enzymes like lipase, polyphenol oxidases, cellulase, amidase, and decarboxylase.
  • Structural Characterization: UV-Vis spectroscopy, HPLC, LC-MS, GC-MS, FT-IR, NMR.
  • Industrial Processes: Extraction, purification, separation, sterilization, pasteurization, atomization, evaporation, lyophilization.
  • Physicochemical Properties: Particle size, color parameters, viscosity, thickness, zeta potential, melting and boiling points, colloidal stability, water sorption isotherms, thermal properties.
  • Biochemistry: Antioxidant tests, microbiological assays, cell culture, cytotoxicity, genotoxicity, biocompatibility, polymer chemistry, food analysis.
  • Technical Skills: Expertise with various analytical instruments and techniques, including FT-IR, NMR, HPLC, LC-MS, SEM, TEM, and many others.
  • Statistical Analysis: ANOVA, Duncan’s Multiple Range tests.
  • Certifications: Management, Biotechnology, Life Cycle Analysis (SimaPro).

🌐 Language and Computer Proficiency

  • Languages:
    • French (Fluent)
    • English (Fluent)
    • Arabic (Native)
  • Computer Skills:
    • Microsoft Office (Word, Excel, PowerPoint)

This summary encapsulates the academic and professional journey of Abdulhadi ALJAWISH, emphasizing his vast experience in biotechnological processes, food science, and enzymatic applications.

 

📊🔬Notable Publication:

 

  • Bioprocesses for the Biodiesel Production from Waste Oils and Valorization of Glycerol
    • Authors: Decarpigny, C., Aljawish, A., His, C., Millares, M., Froidevaux, R.
    • Journal: Energies
    • Year: 2022

 

  • Green synthesis of glyco-phenol by enzymatic coupling between ferulic acid and glucosamine: An ecofriendly procedure
    • Authors: Aljawish, A., Chevalot, I., Paris, C., Muniglia, L.
    • Journal: Biotechnology and Applied Biochemistry
    • Year: 2022

 

  • Enzymatic Oxidation of Ferulic Acid as a Way of Preparing New Derivatives
    • Authors: Aljawish, A., Chevalot, I., Paris, C., Muniglia, L.
    • Journal: BioTech
    • Year: 2022

 

  • Comparing the efficiency of extracting antioxidant polyphenols from spent coffee grounds using an innovative ultrasound-assisted extraction equipment versus conventional method
    • Authors: Beaudor, M., Vauchel, P., Pradal, D., Aljawish, A., Phalip, V.
    • Journal: Chemical Engineering and Processing – Process Intensification
    • Year: 2023

 

  • Synthesis and characterization of release agent from used cooking oil at the concrete/formwork interface
    • Authors: Libessart, L., Anceur, R., Djelal, C., Aljawish, A., Millares, M.
    • Journal: International Journal of Environmental Science and Technology
    • Year: 2023

Dr. Marcello Di Giammarco | Carcinoma | Best Researcher Award

Posted on by Pencis

Dr. Marcello Di Giammarco | Carcinoma | Best Researcher Award

University of Pisa & Institute for Informatics and Telematics (IIT-CNR) | Italy

Author Profile

Scopus

Google Scholar

🧑‍🔬 Marcello Di Giammarco: Ph.D. Student in Biomedical Engineering

🎓 Education

Master in Biomedical Engineering
Università degli Studi 'Roma Tre', Rome, Italy
📜 Degree: 2nd level degree in Biomedical Engineering
📈 Final Mark: 104/110
📚 Thesis: EEG Signal Processing Functional to the Description of Cortical Network in Patients with Acute Ischemic Stroke
📅 2018 - 2020

Bachelor in Electronic Engineering
Università degli Studi 'Roma Tre', Rome, Italy
📜 Degree: 1st level degree in Information Technology
📈 Final Mark: 88/110
📚 Thesis: BCI - Brain Computer Interface for Communication and Rehabilitation
📅 2012 - 2017

💼 Work Experience

Ph.D. Student in Information Engineering
Università di Pisa, Pisa, Italy
📅 11/2022 - Present

📚Responsibilities:

  • Research project 'Artificial Intelligence and Cybersecurity in Medical Sector'
  • Conducting doctoral courses and seminars
  • Co-supervisor for Medical Engineering students
  • Research activities, testing artificial networks for medical purposes
  • Publishing articles and presenting at conferences
  • PC member in KES 2024 and EIAB 2024
  • Final doctoral thesis: Personal research project

🌟Co-relator

Università degli Studi del Molise, CB, Italy
📅 02/2022 - Present

📜Responsibilities:

  • Co-supervisor for Medical Engineering students
  • Number of students supervised: 7
  • Skills acquired: Presenting topics to students, using platforms for remote interaction

🌐 Language Skills

Italian

  • Mother Tongue

English

  • Listening: C1
  • Reading: C1
  • Writing: C1
  • Spoken Interaction: C1
  • Spoken Production: C1

💻 Digital Competences

  • Information and Data Literacy: Independent user
  • Communication and Collaboration: Independent user
  • Digital Content Creation: Basic user
  • Safety: Basic user
  • Problem-Solving: Independent user

🌍Office Automation:

  • Office Suite: Advanced
  • Presentation Software: Advanced
  • Spreadsheets: Intermediate
  • Web Browser: Intermediate
  • Word Processors: Advanced

📱Computer Programming:

  • LaTeX: Intermediate
  • C++: Advanced
  • MATLAB: Advanced
  • Python: Intermediate

🔬Systems and Networks Management:

  • Network Architecture: Advanced
  • Operating Systems: Highly Specialized
  • Linux: Intermediate

🚗 Driving Licence

  • Category B

🏅 Additional Certifications

  • Corso Art.37: Lupi Estintori SRL, 2020-10-25
  • Corso di Primo Soccorso: Lupi Estintori SRL, 2020

🎓 Relevant Courses

  • English for Research Publication and Presentation Purposes: University of Pisa, 2023 (C1 Level)

 

📊🔬Notable Publication:

 

  • Diabetic Retinopathy Detection and Diagnosis by Means of Robust and Explainable Convolutional Neural Networks
    • Authors: Mercaldo, F., Di Giammarco, M., Apicella, A., Martinelli, F., Santone, A.
    • Journal: Neural Computing and Applications
    • Year: 2023

 

  • Explainable Deep Learning for Alzheimer Disease Classification and Localisation
    • Authors: Di Giammarco, M., Iadarola, G., Martinelli, F., Ravelli, F., Santone, A.
    • Journal: Communications in Computer and Information Science
    • Year: 2022

 

  • High Grade Brain Cancer Segmentation by Means of Deep Learning
    • Authors: Di Giammarco, M., Martinelli, F., Mercaldo, F., Santone, A.
    • Journal: Procedia Computer Science
    • Year: 2022

 

  • Deep Learning for Heartbeat Phonocardiogram Signals Explainable Classification
    • Authors: Cesarelli, M., Di Giammarco, M., Iadarola, G., Mercaldo, F., Santone, A.
    • Journal: Proceedings - IEEE 22nd International Conference on Bioinformatics and Bioengineering, BIBE 2022
    • Year: 2022

 

  • Explainable Deep Learning Methodologies for Biomedical Images Classification
    • Authors: Di Giammarco, M., Mercaldo, F., Martinelli, F., Santone, A.
    • Journal: Proceedings - International Conference on Distributed Computing Systems, 2022
    • Year: 2022

Prof Dr. Tao Sun | Nucleic Acid Drug | Best Researcher Award

Posted on by Pencis

Prof Dr. Tao Sun | Nucleic Acid Drug | Best Researcher Award

Nankai University | China

Author Profile

Scopus

Orcid ID

📚 Prof. Tao Sun: Innovator in Oncology and Drug Development

🎓Position:

  • Professor and Doctoral Supervisor, College of Pharmacy, Nankai University, China 🎓

🌟Titles and Awards:

  • National Youth Talent 🌟
  • Winner of the Tianjin Distinguished Youth Scholar 🏆

🔬Research Focus:

  • Molecular mechanisms of malignant tumors 🧬
  • Drug development 💊
  • Pharmacology 🔬

📄Publications:

  • Over 40 papers in prestigious journals, including Advanced Materials, Science Translational Medicine, Hepatology, and Cancer Research, as the first or corresponding author. 📄

📜Patents and Approvals:

  • More than 20 authorized patents 📜
  • 3 new drug clinical approvals ✅

🧪Research Leadership:

  • Principal investigator of 8 major scientific research projects, including Major National Science and Technology Projects and general projects of the National Natural Science Foundation of China. 🧪

🥇Achievements in Education:

  • Instructed students to win the Gold Award in the China International College Students’ “Internet+” Innovation and Entrepreneurship Competition 🥇
  • Recipient of the “Top Ten Award of Scholarly Mentor and Beneficial Friend” at Nankai University 🎖
  • Second Prize winner of the Nankai University Teaching Achievement Award 🥈

💊Summary:

  • Prof. Tao Sun is a distinguished scholar and innovator at Nankai University, renowned for his contributions to oncology, drug development, and pharmacology. His prolific research, numerous patents, and leadership in significant scientific projects underscore his impact in the field. As an educator, he has been instrumental in guiding students to achieve excellence, earning recognition for his mentorship and teaching achievements. 🌟🔬💊

 

📊🔬Notable Publication:

 

Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins

  • Authors: Zhou, B., Zong, S., Zhong, W., … Sun, T., Liu, Y.
    Journal: Oncogene
  • Year: 2020

 

Glycyrrhizic Acid-Induced Differentiation Repressed Stemness in Hepatocellular Carcinoma by Targeting c-Jun N-Terminal Kinase 1

  • Authors: Cai, S., Bi, Z., Bai, Y., … Liu, H., Yang, C.
    Journal: Frontiers in Oncology
  • Year: 2020

 

Twist1-YY1-p300 complex promotes the malignant progression of HCC through activation of miR-9 by forming phase-separated condensates at super-enhancers and relieved by metformin

  • Authors: Meng, J., Han, J., Wang, X., … Liu, H., Sun, T.
    Journal: Pharmacological Research
  • Year: 2023

 

Correction: Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins

  • Authors: Zhou, B., Zong, S., Zhong, W., … Sun, T., Liu, Y.
    Journal: Oncogene
  • Year: 2020

 

YY1 complex promotes quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma

  • Authors: Han, J., Meng, J., Chen, S., … Sun, T., Yang, C.
    Journal: Cancer Research
  • Year: 2019

Assoc Prof Dr. Elcin Aydin | Endometrium Cancer | Best Researcher Award

Posted on by Pencis

Assoc Prof Dr. Elcin Aydin | Endometrium Cancer | Best Researcher Award

University of Health Sciences, Izmir | Turkey

AUTHOR PROFILE

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

  • Assoc Prof Dr. Elçin Aydın’s academic journey began with a strong foundation in medical sciences. She pursued her education with a focus on radiology, demonstrating a keen interest in the diagnostic and therapeutic applications of imaging technologies. Her early academic pursuits laid the groundwork for her specialization in abdominal and genitourinary radiology.

PROFESSIONAL ENDEAVORS

  • Dr. Aydın is currently affiliated with the University of Health Sciences in Izmir, Turkey, and works at Izmir City Hospital. Her professional endeavors have been marked by a commitment to clinical excellence and academic rigor. She has been an active member of prestigious organizations such as the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), the European Congress of Radiology (ECR), and the European Society of Urogenital Radiology (ESUR).

CONTRIBUTIONS AND RESEARCH FOCUS

  • Dr. Aydın has made significant contributions to the field of radiology through her research and clinical work. She has published 14 original articles in SCI-EXP indexed journals and authored 4 case studies, highlighting her expertise in abdominal and genitourinary radiology. Her research focuses on the diagnostic accuracy and clinical applications of imaging techniques in these areas, aiming to improve patient outcomes through advanced radiological practices.

IMPACT AND INFLUENCE

  • Through her scholarly publications and clinical practice, Dr. Aydın has had a considerable impact on the field of radiology. Her work is frequently cited by peers, reflecting the influence of her research on contemporary radiological practices. Her involvement in ESGAR, ECR, and ESUR underscores her influence within the radiological community, where she contributes to the advancement of knowledge and practice standards.

ACADEMIC CITATIONS

  • Dr. Aydın’s research has garnered significant academic attention, with numerous citations in prominent radiological journals. Her studies on abdominal and genitourinary radiology are referenced by other researchers and clinicians, indicating the high regard in which her work is held. This academic recognition is a testament to the quality and relevance of her research contributions.

LEGACY AND FUTURE CONTRIBUTIONS ON ENDOMETRIUM CANCER

  • Dr. Aydın’s legacy in the field of radiology is characterized by her dedication to advancing medical imaging and improving patient care. Looking ahead, she is poised to continue her impactful research and clinical work, with a focus on innovative imaging techniques and their applications in abdominal and genitourinary radiology. Her future contributions are expected to further enhance the understanding and practice of radiology, benefiting both the medical community and patients.

OTHER IMPORTANT TOPICS

TEACHING AND MENTORSHIP

  • In addition to her research and clinical responsibilities, Dr. Aydın is deeply committed to teaching and mentoring the next generation of radiologists. Her role at the University of Health Sciences allows her to shape the education and training of medical students and residents, ensuring the continued growth and development of the field.

COLLABORATIVE PROJECTS

  • Dr. Aydın actively engages in collaborative projects with other institutions and researchers. These collaborations enable the sharing of knowledge and expertise, fostering innovation and improving radiological practices globally. Her collaborative efforts have resulted in several joint publications and research initiatives.

PROFESSIONAL DEVELOPMENT

  • Continuous professional development is a cornerstone of Dr. Aydın’s career. She regularly participates in international conferences, workshops, and training programs to stay abreast of the latest advancements in radiology. This commitment to lifelong learning ensures that she remains at the forefront of her field, providing the highest standard of care to her patients.

 

📊🔬Notable Publication:

Extrapulmonary Tuberculosis: An Old but Resurgent Problem

  • Authors: Baykan, A.H., Sayiner, H.S., Aydin, E., Inan, I., Erturk, S.M.
    Journal: Insights into Imaging
  • Year: 2022

 

Quantitative Analysis of the Olfactory System in COVID-19: An MR Imaging Study

  • Authors: Altunisik, E., Baykan, A.H., Sahin, S., Aydin, E., Erturk, S.M.
    Journal: American Journal of Neuroradiology
  • Year: 2021

 

Primary Breast Tuberculosis: Imaging Findings of a Rare Disease

  • Authors: Baykan, A.H., Sayiner, H.S., Inan, I., Aydin, E., Erturk, S.M.
    Journal: Insights into Imaging
  • Year: 2021

 

Reliability of Real-Time Sonoelastography in the Diagnosis of Supraspinatus Tendinopathy

  • Authors: Aydın, E., Söylev, G.Ö., Muratlı, S.K., Tekindal, M.A., Ağıldere, M.
    Journal: Ultrasound Quarterly
  • Year: 2021

 

Optical Coherence Tomography-Angiography Findings of Prediabetic Patients

  • Authors: Emre, S., Altin, C., Ulusoy, M.O., Aydin, E.
    Journal: Oman Journal of Ophthalmology
  • Year: 2024

Dr. Stavros Melemenidis | Micrometastases | Best Researcher Award

Posted on by Pencis

Dr. Stavros Melemenidis | Micrometastases | Best Researcher Award

Stanford University School of Medicine | United States

Author Profile

Scopus

Orcid id

📚 Biography: Dr. Stavros Melemenidis

🎓 Education

  • DPhil in Radiation Biology – University of Oxford, Dept. Radiation Oncology, Oxford, UK (2010-2015)
    • Mentors: Prof. Nicola Sibson, Prof. Ruth Muschel
    • Thesis: Development of molecular targeted imaging methods for the detection of lung metastasis and angiogenesis
  • M.Sc. in Radiation Biology – University of Oxford, Dept. Radiation Oncology, Oxford, UK (2009-2010)
  • M.Sc. in Radiometrics – University of Liverpool, Dept. Physics, Liverpool, UK (2008-2009)
  • B.Sc. in Physics: Medical Applications – University of Liverpool, Dept. Physics, Liverpool, UK (2005-2008)
  • A.Eng. in PC Systems and Peripheral Equipment – IIEK Neapoleos, Technical College, Thessaloniki, Greece (1998-2000)
  • Cert. Medical Physics – UCLA, Dept. Radiation Oncology, Los Angeles, CA, USA (2022-2023)

🏢 Current Position

  • Director of Pre-clinical Radiotherapy – Dept. of Radiation Oncology, Stanford University (Jan 2023-present)
  • Research Scientist – Div. of Radiation Therapy, Stanford University (Feb 2020-present)

🔬 Research Experience & Skills

  • Stanford University, Dept. Radiation Oncology, Stanford, CA
    • Director of Pre-clinical Radiotherapy Core (Jun 2023-present)
      • Calibration of preclinical orthovoltage irradiators
      • Monthly and annual quality checks for dosimetric consistency
      • Innovation in animal radiation shielding via 3D design and additive manufacturing
    • Basic Life Research Scientist at Div. of Radiation Therapy (Jun 2020-present)
      • Pioneering preclinical ultra-high dose-rate (FLASH) irradiation experiments
      • Specializing in 3D-designed radiation shielding for animal safety
      • Expertise in dosimetry using radiochromic film and ion chambers
      • Development of animal models involving tumor implantation and microsurgical techniques
    • Postdoctoral Fellow (Feb 2016-Jun 2020)
      • Advisor: Edward E. Graves
      • Led development of in vivo mouse tumor models integrating imaging, radiotherapy, and immunotherapy
      • Specialized in ultrasound-guided injection techniques
      • Conducted research into immune cell migration with a focus on macrophage imaging
      • Evaluated radioprotective strategies for healthy tissue through drug development
    • Postdoctoral Fellow at University of Oxford, Dept. Radiation Oncology (Jan 2015-Sep 2015)
      • Advisor: Nicola R. Sibson
      • Designed and evaluated innovative imaging probes for metastasis detection and angiogenesis visualization
      • Developed dual MRI/PET probe for metastasis and MRI probe for angiogenesis
      • Managed international research collaboration with Duke University

📜 Selected Publications

  • In vivo PET detection of lung micrometastasis by targeting endothelial VCAM-1. Int J Mol Sci, 2024.
  • Multi-institutional audit of FLASH and conventional dosimetry with a 3D-printed anatomically realistic mouse phantom. Int J Radiat Oncol Biol Phys, 2023.
  • Exploring deep learning for estimating the isoeffective dose of FLASH irradiation from mouse intestinal histological images. J Radiat Oncol Biol Phys, 2023.
  • Human enteroids as a tool to study conventional and ultra-high dose rate radiation. Integr Biol (Camb), 2023.
  • Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1. J Clin Invest, 2023.

🏆 Awards & Honors

  • Recognition of Excellent Research: Aegean Conferences: 12th International Conference on Complement Therapeutics, Rhodes, Greece, 2019
  • Poster Prize: Aegean Conferences: 3rd International Conference for Tumor Microenvironment and Cellular Stress, Greece, Mykonos, 2014

🗣️ Conference Presentations

  • Oral Presentation: Demonstrating FLASH effectiveness against CONV dose rates, 34th ACRO Summit, Orlando, FL, March 2024
  • Poster Presentation: Anatomically Realistic 3D Printed Mouse Phantom for Multi-Institutional Benchmarking of FLASH and CONV Irradiation, 65th ASTRO Annual Meeting San Diego, USA, Oct 2023

📞 References

  • Prof. Billy W Loo Jr: Professor of Radiation Oncology (Radiation Therapy), Stanford University School of Medicine
  • Prof. Edward E Graves: Associate Professor of Radiation Oncology and Director of Molecular Imaging Program, Stanford University School of Medicine
  • Prof. Frederick M Dirbas: Associate Professor of Surgery (General Surgery), Stanford University School of Medicine

Dr. Stavros Melemenidis is a distinguished figure in radiation oncology, with a profound impact on preclinical radiotherapy and FLASH irradiation research. His contributions to innovative imaging techniques and his dedication to advancing cancer treatment methodologies are reflected in his extensive publication record and numerous accolades.

📊🔬Notable Publication:

 

 

 

 

Prof. R. StephanieHuang – Oncology and Precision Medicine – Best Researcher Award 

Posted on by Pencis

Prof. R. StephanieHuang - Oncology and Precision Medicine - Best Researcher Award 

University Of Minnesota - Minneapolis, MN - United States

Author Profile

Scopus 

Orcid

Early Academic Pursuits

Dr. Rong Stephanie Huang's academic journey began with her pursuit of pharmacology at the University of Minnesota, where she eventually earned the title of Distinguished McKnight University Professor. Her early academic pursuits laid the foundation for her distinguished career in the field.

Professional Endeavors

Throughout her career, Dr. Huang has held prestigious academic appointments, including her current position in the Department of Experimental and Clinical Pharmacology at the University of Minnesota. Her commitment to advancing pharmacology is evident in her leadership roles and contributions to various professional societies.

Contributions and Research Focus on Oncology and Precision Medicine

Dr. Huang's research primarily focuses on personalized and precision medicine, particularly in oncology. Her work aims to tailor treatments to individual patients by understanding the genetic and molecular mechanisms underlying cancer progression. This research has significant implications for improving patient outcomes in cancer treatment.

Impact and Influence

As a respected leader in pharmacology, Dr. Huang's influence extends beyond her research. Her leadership roles in organizations such as the International Pharmaceutical Federation (FIP) highlight her dedication to advancing the field on a global scale. Her contributions have shaped the landscape of personalized medicine and oncology research.

Academic Citations

Dr. Huang's research has garnered substantial attention within the academic community, evidenced by the numerous citations her work has received. Her findings have contributed to advancing knowledge in pharmacology, particularly in the realm of personalized medicine and cancer research.

Legacy and Future Contributions

Dr. Huang's legacy is characterized by her significant contributions to pharmacology and personalized medicine. Her ongoing leadership roles and mentorship efforts ensure that her impact will endure for future generations of pharmacologists. As she continues her research and advocacy, Dr. Huang will undoubtedly leave a lasting legacy in the field.

Notable Publications

Computational Modeling to Identify Drugs Targeting Metastatic Castration-Resistant Prostate Cancer Characterized by Heightened Glycolysis.

Integration of Computational Pipeline to Streamline Efficacious Drug Nomination and Biomarker Discovery in Glioblastoma.

Integration of pan-cancer cell line and single-cell transcriptomic profiles enables inference of therapeutic vulnerabilities in heterogeneous tumors.

A review of computational methods for predicting cancer drug response at the single-cell level through integration with bulk RNAseq data.

 

 

 

Ms. Hao Li – Tumor Immunology – Young Scientist Award

Posted on by Pencis

Ms. Hao Li - Tumor Immunology - Young Scientist Award

First Hospital of China Medical University - China

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Li Hao began his academic journey at Dalian Medical University in September 2015, majoring in Immunology, Biochemistry, Surgery, and Internal Medicine. During this period from 2015 to 2020, he laid the foundational knowledge in the medical sciences that would serve as the basis for his future specialization. His undergraduate studies provided him with a comprehensive understanding of the human body's immune system, biochemistry, surgical techniques, and internal medicine.Li Hao pursued his Master's degree in Emergency Medicine and Molecular Biology at China Medical University. This advanced academic pursuit enabled him to delve deeper into specialized areas of medicine, focusing on emergency care and the molecular mechanisms underlying various medical conditions.

PROFESSIONAL ENDEAVORS

In May 2021, Li Hao started his professional career as a Resident Physician at the First Hospital of China Medical University. During his tenure from May 2021 to August 2021, he gained hands-on experience in clinical settings, honing his skills in medical records writing and cardiopulmonary resuscitation (CPR). This role allowed him to apply his theoretical knowledge from his undergraduate studies in a practical setting, preparing him for more specialized roles in the medical field.In June 2023, Li Hao transitioned to the role of an Assistant at the First Hospital of China Medical University, where he continues to work to the present day. As an Assistant, he has been involved in research projects and clinical work, further expanding his expertise and contributing to advancements in the medical field.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Li Hao's research interests are diverse and interdisciplinary, focusing on the areas of nanomaterials, hepatocellular carcinoma, and macrophage biology. His research aims to explore innovative approaches and treatments for these medical conditions, leveraging the latest advancements in molecular biology and emergency medicine.

IMPACT AND INFLUENCE

Li Hao's contributions to the medical field extend beyond his professional roles, as he actively engages in research and academic pursuits that have the potential to make a significant impact. His research in nanomaterials, hepatocellular carcinoma, and macrophage biology could lead to breakthroughs in treatment options and improve patient outcomes in these areas.

ACADEMIC SITES

Li Hao's academic achievements and research contributions have likely been cited in various scientific publications and conferences. His interdisciplinary research in nanomaterials, hepatocellular carcinoma, and macrophage biology demonstrates his commitment to advancing medical science and contributing valuable insights to the academic community.

LEGACY AND FUTURE CONTRIBUTIONS

As Li Hao continues to pursue his career in emergency medicine and molecular biology, his interdisciplinary research and clinical experience will undoubtedly leave a lasting legacy in the medical field. His dedication to improving patient care and advancing medical science positions him as a promising young professional with the potential to make significant contributions to the future of healthcare.

NOTABLE PUBLICATIONS

Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors.  2024

Glutamate Chemical Exchange Saturation Transfer (GluCEST) MRI to Evaluate the Rapid Antidepressant Effects of Ketamine in the Hippocampus of Rat Depression Model. 2024 (1)

Preclinical multi-physiologic monitoring of immediate-early responses to diverse treatment strategies in breast cancer by optoacoustic imaging. 2024

Glutamate alterations in the premature infant brain during different gestational ages with glutamate chemical exchange saturation transfer imaging: a pilot study. 2023 (1)

Xenon inhalation attenuates neuronal injury and prevents epilepsy in febrile seizure Sprague-Dawley pups. 2023 (1)

 

Prof. Paolo De Simone – Oncology Therapy – Most Liked Article Award

Posted on by Pencis

Prof. Paolo De Simone - Oncology Therapy - Most Liked Article Award

UNIVERSITY OF PISA - Italy

Author Profile

Google Scholar
Scopus
Orcid

EARLY ACADEMIC PURSUITS

Paolo De Simone graduated summa cum laude in Medicine and Surgery from the University of Rome La Sapienza. His thesis was titled "Laparoscopic cholecystectomy in the treatment of gallstone lithiasis: prospective analysis of the results of our experience" under the supervision of Prof. Raffaello Cortesini.He earned his Specialist Diploma in General Surgery summa cum laude from the University of Rome “La Sapienza”. His thesis focused on "The role of laparoscopic surgery in the treatment of benign and malignant gastric pathologies" under the guidance of Prof. Raffaello Cortesini.Paolo De Simone achieved his PhD summa cum laude in Surgical Pathophysiology.

PROFESSIONAL ENDEAVORS

Registered in the Order of Doctors-Surgeons and Dentists of the Province of Rome with registration number 46702. He also qualified to practice the medical-surgical profession at the University of Rome “La Sapienza”. He served as a Foreign Resident-Assistant at the General Surgery Service of CHU André Vésale, Université Libre de Bruxelles, Montigny-Le-Tilleul, Belgium, and at the Thoracic and Vascular Surgery Service of the Hospital Avicenne, Bobigny, France. Paolo De Simone held several medical director positions:General Surgery Unit, Civil Hospital of Vittorio Veneto (TV),Organ Transplant Unit, San Salvatore Civil Hospital, L'Aquila,Service de Chirurgie Digestive, Hopital Erasme, Université Libre de Bruxelles, Brussels,University Liver Transplantology Unit, Pisa University Hospital.Currently, he is an Associate Professor of Surgery at the University of Pisa. He was elected Director of the School of Specialization in Surgery of the Digestive System and serves as Director of the Liver Surgery and Liver Transplant Unit, AOUP.

CONTRIBUTIONS AND RESEARCH FOCUS ON ONCOLOGY THERAPY

Appointed as the Coordinator of the regional liver transplant program by DGRT of 17 December 2018, n. 1450. He also managed clinical, scientific, and educational coordination of terminal liver failure and liver transplantation (DG AOUP Resolution 852 of 09/20/2023).His research has covered areas like laparoscopic cholecystectomy, treatment of benign and malignant gastric pathologies, and liver transplantology.

IMPACT AND INFLUENCE

As Coordinator of the Liver Transplant Program of the Tuscany Region, he has significantly contributed to the advancement of liver transplantation in the region.

LEGACY AND FUTURE CONTRIBUTIONS

Paolo De Simone's legacy lies in his extensive contributions to the fields of general surgery, liver surgery, and liver transplantology. His future contributions are anticipated in enhancing liver transplant programs, furthering research in surgical pathophysiology, and mentoring the next generation of surgeons through his academic roles.

NOTABLE PUBLICATIONS

Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation.

First-in-human liver transplantation from a centenarian deceased donor after brain death.

Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation.

An Unexpected Case of Opisthorchis felineus Infection Revealed during Liver Transplantation.

An overview of the efficacy and safety of everolimus in adult solid organ transplant recipients.

 

Dr. Francesco Raspagliesi – Gynecologic Oncology – Best Researcher Award

Posted on by Pencis

Dr. Francesco Raspagliesi - Gynecologic Oncology - Best Researcher Award

Fondazione IRCCS Istituto nazionale Tumori di Milano - Italy  

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Francesco Raspagliesi began his academic journey with a Degree in Medicine and Surgery from the University of Catania, Italy, which he completed on March 7, 1981. Following this foundational education, he obtained qualifications to practice medicine in 1981 and specialized in Obstetrics and Gynecology from the University of Catania in 1985 and 1988. These early academic pursuits laid the groundwork for his future professional endeavors in the field of gynecologic oncology.

PROFESSIONAL ENDEAVORS

From 1985 to 1992, Raspagliesi served as a Research Fellow at the Fondazione IRCCS Istituto Nazionale Tumori di Milano. He continued his professional growth at the same institution, becoming a Dirigente Medico di 1° Livello from 1992 to 1999 and advancing to Dirigente Medico di 2° Livello Gynecologic Oncology Unit Director from 1999 to 2019. His long-standing association with the Fondazione IRCCS Istituto Nazionale Tumori di Milano demonstrates his commitment and dedication to the field of gynecologic oncology and patient care.

CONTRIBUTIONS AND RESEARCH FOCUS ON GYNECOLOGIC ONCOLOGY

Throughout his career, Raspagliesi has made significant contributions to the field of Obstetrics and Gynecology. His research and clinical work have focused on gynecologic oncology, particularly in the treatment and management of gynecologic cancers. His expertise and leadership as the Gynecologic Oncology Unit Director have contributed to advancements in the diagnosis, treatment, and care of patients with gynecologic cancers.

IMPACT AND INFLUENCE

As a respected figure in the field of gynecologic oncology, Raspagliesi's work has had a profound impact on patient care, research, and education. His leadership roles and contributions to research have helped shape the way gynecologic cancers are treated and managed, influencing clinical practice and improving patient outcomes.

LEGACY AND FUTURE CONTRIBUTIONS

Francesco Raspagliesi's legacy in the field of Obstetrics and Gynecology is characterized by his dedication to patient care, leadership in gynecologic oncology, and contributions to research and education. His continued commitment to advancing the field through research, mentorship, and clinical practice ensures that his influence will be felt by future generations of gynecologic oncologists.

NOTABLE PUBLICATIONS

Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group.  2024

Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes. 2024

Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs.  2024

Impact of Cold Ischemia on the Stability of 1H-MRS-Detected Metabolic Profiles of Ovarian Cancer Specimens. 2024

Concurrent Endometrial Cancer in Women with Atypical Endometrial Hyperplasia: What Is the Predictive Value of Patient Characteristics? (2) 2024